Australia markets open in 5 hours 42 minutes

Inspire Medical Systems, Inc. (INSP)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
162.38-1.29 (-0.79%)
At close: 04:00PM EDT
162.00 -0.38 (-0.23%)
After hours: 07:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.82B
Enterprise value 4.41B
Trailing P/E N/A
Forward P/E 1.00k
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.23
Price/book (mrq)8.19
Enterprise value/revenue 6.67
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 3-47.45%
S&P500 52-week change 325.69%
52-week high 3330.00
52-week low 3123.27
50-day moving average 3192.37
200-day moving average 3186.43

Share statistics

Avg vol (3-month) 3606.12k
Avg vol (10-day) 3445.87k
Shares outstanding 529.71M
Implied shares outstanding 629.71M
Float 829.17M
% held by insiders 11.98%
% held by institutions 1108.60%
Shares short (15 May 2024) 41.85M
Short ratio (15 May 2024) 42.3
Short % of float (15 May 2024) 47.17%
Short % of shares outstanding (15 May 2024) 46.24%
Shares short (prior month 15 Apr 2024) 42.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -2.38%
Operating margin (ttm)-9.28%

Management effectiveness

Return on assets (ttm)-3.58%
Return on equity (ttm)-2.88%

Income statement

Revenue (ttm)660.91M
Revenue per share (ttm)22.45
Quarterly revenue growth (yoy)28.20%
Gross profit (ttm)N/A
EBITDA -32.9M
Net income avi to common (ttm)-15.73M
Diluted EPS (ttm)-0.54
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)441.36M
Total cash per share (mrq)14.85
Total debt (mrq)24.5M
Total debt/equity (mrq)4.16%
Current ratio (mrq)7.93
Book value per share (mrq)19.85

Cash flow statement

Operating cash flow (ttm)34.86M
Levered free cash flow (ttm)4.29M